Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Daiichi Sankyo
Fish and Richardson
Teva
Merck
Cipla
Farmers Insurance
Baxter

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,910,225

« Back to Dashboard

Summary for Patent: 4,910,225
Title: Locally administrable therapeutic composition for inflammatory disease
Abstract:This invention relates to a locally administrable therapeutic composition for inflammatory disease which is characterized by comprising benzoylphenylacetic acid of the formula ##STR1## (wherein R is a hydrogen or halogen atom), or a salt thereof, or the hydrate of said acid or salt, as active ingredient. An ophthalmic composition according to the invention can treat effectively inflammatory eye disease by topical application, is not an irritant to the eye, and has a superior effect to conventional drugs of the same or similar type. The aqueous composition prepared in accordance with this invention has excellent stability and can be used advantageously as a nasal or otic composition as well as an ophthalmic one in the treatment of inflammatory otic or nasal disease.
Inventor(s): Ogawa; Takahiro (Nishinomiya, JP), Kuribayashi; Yoshikazu (Kobe, JP), Ushio; Kazumichi (Nishinomiya, JP), Ohtori; Akira (Nara, JP)
Assignee: Senju Pharmaceutical Co., Ltd. (Osaka, JP) A. H. Robins Company, Incorporated (Richmond, VA)
Application Number:07/301,033
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Formulation;

Drugs Protected by US Patent 4,910,225

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,910,225

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan63-16683Jan 27, 1988

International Patents Family Members for US Patent 4,910,225

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 609932 ➤ Try a Free Trial
Canada 1325382 ➤ Try a Free Trial
Germany 68902649 ➤ Try a Free Trial
European Patent Office 0326915 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Cerilliant
Healthtrust
US Department of Justice
Medtronic
Boehringer Ingelheim
Daiichi Sankyo
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.